Jointown Pharmaceutical Group announced that it has received the registration approval from the China Securities Regulatory Commission to issue preferred shares to specific entities. The total number of shares issued is 0.179 billion, and the total amount of funds raised is 1.79 billion yuan. The face value is 100 yuan, with a coupon rate of 5.00%. There is no investor put option for the preferred shares. The preferred shares will be listed and traded on the Shanghai Stock Exchange Integrated Business Platform starting from September 24, 2024.
九州通：向特定对象发行1.79亿股优先股获注册批复
Jointown Pharmaceutical Group: Registered approval has been obtained for the issuance of 0.179 billion preferred shares to specific entities.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated